期刊文献+

草酸艾司西酞普兰与文拉法辛治疗老年抑郁症的疗效及不良反应比较 被引量:3

Effect and of adverse reactions compare of escitalopram oxalate and venlafaxine in the treatment of senile depression
下载PDF
导出
摘要 目的比较抗抑郁药草酸艾司西酞普兰与文拉法辛治疗老年抑郁症的疗效及不良反应。方法将64例老年抑郁症患者随机分为A组和B组各32例,A组予以草酸艾司西酞普兰治疗,B组予以文拉法辛治疗,疗程均为8周。2组治疗前和治疗后第2、4、6、8周末分别采用汉密尔顿抑郁量表(HAMD)、不良反应量表(TESS)评定疗效及不良反应。结果 2组临床疗效和HAMD评分变化比较差异均无统计学意义(P>0.05)。2组不良反应均较少,但A组较B组更少。结论草酸艾司西酞普兰对老年抑郁症疗效显著,不良反应少,安全有效,患者依从性更好。 Objective To compare the effect and adverse reactions of Escitalopram Oxatate and Venlafaxine in the treatment of senile depression. Methods 64 cases of old patients with depression were randomly divided into group A and group B, each of 32 cases. The group A was treated with escitalopram Oxalate,while the group B was treated with venlafaxine. Both groups were treated for 8 weeks. The Hamilton Depression Scale (HAMD) and the TESS were used to assess the effect and side effect before and 2,4,6,8 weeks after treatment. Results The efficacy and HAMD score of 2 groups were similar , there was no statistical difference between the 2 groups (P 〉 0.05 ). The adverse reaction of group A was lighter than that of the group B, and the difference was statistically significant ( P 〈 0.05 ). Conclusion It is quite effective to cure the senile depression with escitalopram oxalate. And the side effect of escitalopram oxalate was lighter than venlafaxine. The patients of group A may have better compliance.
出处 《临床合理用药杂志》 2012年第32期12-13,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 草酸艾司西酞普兰 文拉法辛 抑郁症 老年 疗效 不良反应 Escitalopram oxalate Venlafaxine Senile depression, elderly Therapeutic effect Side effect
  • 相关文献

参考文献1

  • 1中华医学会精神科分会.中国精神障碍分类与诊断标准[M] 3版[M].济南:山东科学技术出版社,2001.31-6.

共引文献122

同被引文献26

  • 1马建东,钱东丽,李转清.米氮平治疗抑郁症及焦虑症的临床疗效比较[J].临床心身疾病杂志,2004,10(2):83-84. 被引量:18
  • 2胡纪泽,吴东辉,刘仁刚,丁树明,冯征,董松玉,曹长安,胡赤怡,林雄标,舒明跃,吴怀安,方莉,唐卓如,包刚.抑郁障碍共患其他精神障碍的研究[J].中华精神科杂志,2005,38(2):98-100. 被引量:38
  • 3陈登榜,刘延友,杨波,李葳,郑航,王正荣.海马β_1和β_2肾上腺素受体与抑郁症的关系[J].四川生理科学杂志,2006,28(2):50-51. 被引量:9
  • 4Berlim M T,Turecki G. Definition, assessment, and staging of treat- ment-resistant refractory major depression:a review of current con- cepts and methods[J]. Can J Psychiatry i 2007 , 52 (1):46. DOI: 10. 1016/S0006-3223 (03)00088-X.
  • 5Hu T. The economic burden of depression and reimbursement pol- icy in the Asia Pacific region[ J]. AuStralasian Psychiatry,2004, 12( supl ) : s1 1-s15.
  • 6Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Co- morbidity Survey Replication [ J ]. Arch Gen Psychiatry, 2005,62 ( 6 ) :617-627. DOI : 10. 1001/archpsyc. 62.6. 617.
  • 7Yatham LN, Kennedy SH, 0 Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and con- troversies[ J ]. Bipolar Disorders, 2005,7( s3 ) : 5-69. DOI: 10. llll/j. 1399-5618. 2005. 00188. x.
  • 8Zimmerman M, McDermut W, Mattia JI. Frequency of anxiety dis- orders in psychiatric outpatients with major depressive disorder [ J ]. Am J Psychiatry,2014,157 (8) : 1337-1340. DOI: 10.1176/ appi. ajp. 157.8. 1337.
  • 9Spadone C. Effects of escitalopram on anxiety symptoms in de- pression [ J ]. L "Encephale, 2001,28 ( 5 Pt 1 ) : 461-465. DOI : ENC-10-2002-28-5-0013-7006-101019-ART11.
  • 10Zeralan FP, Garver DL. Depression and antidepressant therapy: re- ceptor dynamics[ J]. Progress in Neum-Psyehopharmacology and Biological Psychiatry, 1990, 14 (4):503-523. DOI: 10. 1016/ 0278-5846 ( 90 ) 90004-Z.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部